Publications by authors named "Kaylee Williamson"

Claim this Profile
C
Changes in long-acting β-agonist utilization after the FDA's 2010 drug safety communication.
Daniel M Hartung, Luke Middleton, Sheila Markwardt, Kaylee Williamson, Kathy Ketchum

Clin Ther· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis